Citadel Advisors’s Kazia Therapeutics KZIA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,210
| Closed | -$26K | – | 6415 |
|
2024
Q3 | $26K | Buy |
1,210
+1,119
| +1,230% | +$24K | ﹤0.01% | 5282 |
|
2024
Q2 | $1.04K | Buy |
+91
| New | +$1.04K | ﹤0.01% | 5705 |
|
2024
Q1 | – | Sell |
-256
| Closed | -$5.75K | – | 6525 |
|
2023
Q4 | $5.75K | Buy |
+256
| New | +$5.75K | ﹤0.01% | 5599 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 6425 |
|
2022
Q3 | – | Sell |
-455
| Closed | -$95K | – | 6337 |
|
2022
Q2 | $95K | Buy |
+455
| New | +$95K | ﹤0.01% | 5313 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 6773 |
|
2021
Q4 | – | Sell |
-352
| Closed | -$202K | – | 6847 |
|
2021
Q3 | $202K | Buy |
352
+96
| +38% | +$55.1K | ﹤0.01% | 5416 |
|
2021
Q2 | $126K | Buy |
+256
| New | +$126K | ﹤0.01% | 5853 |
|
2019
Q4 | – | Sell |
-256
| Closed | -$49K | – | 4886 |
|
2019
Q3 | $49K | Sell |
256
-153
| -37% | -$29.3K | ﹤0.01% | 4362 |
|
2019
Q2 | $49K | Buy |
+409
| New | +$49K | ﹤0.01% | 4358 |
|
2017
Q3 | – | Sell |
-90
| Closed | -$16K | – | 3902 |
|
2017
Q2 | $16K | Buy |
90
+26
| +41% | +$4.62K | ﹤0.01% | 3549 |
|
2017
Q1 | $18K | Buy |
+64
| New | +$18K | ﹤0.01% | 3545 |
|
2016
Q4 | – | Sell |
-88
| Closed | -$35K | – | 3872 |
|
2016
Q3 | $35K | Buy |
+88
| New | +$35K | ﹤0.01% | 3339 |
|
2015
Q3 | – | Sell |
-61
| Closed | -$49K | – | 4163 |
|
2015
Q2 | $49K | Buy |
+61
| New | +$49K | ﹤0.01% | 3436 |
|
2014
Q2 | – | Sell |
-63
| Closed | -$52K | – | 3595 |
|
2014
Q1 | $52K | Buy |
+63
| New | +$52K | ﹤0.01% | 3283 |
|